Laura Clague, Chief Financial Officer at Travere Therapeutics, Inc. (TVTX), sold 4,000 shares at $19.46 ($77K) on 2021-05-12, disclosed to the SEC on 2021-05-13.
Scheduled sale ($77k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.14 | 2,000 | $38K | 49.6% |
| 2 | $19.46 | 2,000 | $39K | 50.4% |
| Total | $19.30 avg | 4,000 | $77K | 100% |
| Filing → |
| TVTX | SELL | 2022-02-02 | $34K | — | Filing → |
| TVTX | SELL | 2022-01-26 | $103K | — | Filing → |
| TVTX | SELL | 2022-01-12 | $206K | — | Filing → |